Evidence map›Paper›PMID 40715149›Full record

ArticleScientific reports2025

Secondary ions mass spectrometric method for assessing surface density of pegylated liposomal nanomedicines.

Francesco Fumagalli, Alexander Welle, Guillaume Bucher, Silvia Appleton, Jessica Ponti, Giacomo Ceccone, Luigi Calzolai, Dora Mehn

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francesco FumagalliEuropean Commission, Joint Research Centre (JRC), Ispra, Italy. francesco-sirio.fumagalli@ec.europa.eu.
Alexander WelleKarlsruhe Nano Micro Facility (KNMF), Karlsruhe Institute of Technology (KIT), 76344, Eggenstein-Leopoldshafen, Germany.
Guillaume BucherEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Silvia AppletonEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Jessica PontiEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Giacomo CecconeEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Luigi CalzolaiEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Dora MehnEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.

Funding

European Commission Joint Research Centre - Exploratory Research Program Call 2023 PANGOLINNFFA-Europe Staff Exchanges for Access Providers ID425 - 2024
6 · The paper itself

Abstract

Liposomal drug delivery relies on polyethylene glycol (PEG) coating since it is essential for preserving the stability and increasing the plasma half-life of the lipid-based nanocarriers, and therefore it represents a critical quality attribute of nanomedicine formulations. Due to the complexity of their therapeutic action and the implications if they prove to be ineffective, decision-making in nanomedicine development requires statistically meaningful correlations between design principles and their biophysical properties. Precise characterization of PEG functional coatings is essential for quality control of PEGylated liposomes, it is required not only to measure the total amount of nanoparticle incorporated PEG-chains but also their abundance and conformation at the nanoparticle external surface. In this study, we developed a methodology to characterize PEG-coatings of PEGylated liposomes using a cryogenic protocol for time-of-flight secondary ions mass spectrometry (ToF-SIMS). The method was applied to liposomes formulated with varying PEG-lipid contents in the formulation and the measurements successfully distinguished PEGylated liposomes based on their PEG-lipid content in the liposome outer membranes. These results indicate that the cryogenic ToF-SIMS method could be potentially used to control the quality of PEGylated liposomes not only for research and but also for drug manufacturing processes.

Indexed as

LiposomesNanomedicinePolyethylene GlycolsSpectrometry, Mass, Secondary IonDrug Delivery SystemsNanoparticlesSurface PropertiesLiposomesPolyethylene GlycolsAdvanced functional coatingsCryogenic methodsLipid-based nanoparticlesNanomedicinesPEGSurface propertiesVacuum methods

Identifiers

PMID40715149
PMCPMC12297254

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.